Senyene E. Hunter

Senyene E. Hunter

Auto-generated profile, based on publicly available information

Senyene E. Hunter

Department of Neurology University of North Carolina School of Medicine Chapel Hill North Carolina USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2025 in Pediatric Neurology
Verified
Journal Article
Closed access
Debopam SamantaDebopam Samanta
Debopam Samanta
SBSonal Bhatia
Sonal Bhatia
SHSenyene E. Hunter
Senyene E. Hunter
CRChethan K. Rao
Chethan K. Rao
KXKatherine Xiong
Katherine Xiong
JSJohn M. Schreiber
John M. Schreiber

11 July 2024 in Journal Of Clinical Neurophysiology
Verified
Journal Article
Open access
JMJohn R. Mytinger
John R. Mytinger
DADara V. F. Albert
Dara V. F. Albert
SAShawn C. Aylward
Shawn C. Aylward
CBChristopher W. Beatty
Christopher W. Beatty
SBSonam Bhalla
Sonam Bhalla
DSDaniel W. Shrey
Daniel W. Shrey
Purpose: The best possible outcomes in infantile epileptic spasms syndrome require electroclinical remission; however, determining electrographic remission is not straightforward. Although the determination of hypsarrhythmia has inadequate interrater reliability (IRR), the Burden of AmplitudeS and Epileptiform Discharges (BASED) score has shown promise for the reliable interictal assessment of infantile epileptic spasms syndrome. Our aim was to develop a BASED training program and assess the IRR among learners. We hypothesized moderate or better IRR for the final BASED score and the presence or absence of epileptic encephalopathy (+/−EE). Methods: Using a web-based application, 31 learners assessed 12 unmarked EEGs (length 1–6 hours) from children with infantile epileptic spasms syndrome. Results: For all readers, the IRR was good for the final BASED score (intraclass correlation coefficient 0.86) and +/−EE (Marginal Multirater Kappa 0.63). For all readers, the IRR was fair to good for all individual BASED score elements. Conclusions: These findings support the use of our training program to quickly learn the BASED scoring method. The BASED score may be a valuable clinical and research tool. Given that the IRR for the determination of epileptic encephalopathy is not perfect, clinical acumen remains paramount. Additional experience with the BASED scoring technique among learners and advances in collaborative EEG evaluation platforms may improve IRR.

10 October 2025 in Pediatric Neurology
Verified
Journal Article
Closed access
CBChristina Briscoe
Christina Briscoe
AKAkshat Katyayan
Akshat Katyayan
CHChellamani Harini
Chellamani Harini
SHShaun A. Hussain
Shaun A. Hussain
SBSonam Bhalla
Sonam Bhalla
ANAdam L. Numis
Adam L. Numis

22 September 2025 in Journal of Child Neurology
Verified
Journal Article
Closed access
SDSweta Dubey
Sweta Dubey
SHSenyene E. Hunter
Senyene E. Hunter
CDChristal G. Delagrammatikas
Christal G. Delagrammatikas
GPGloria Pinero
Gloria Pinero
VEVimala Elumalai
Vimala Elumalai
MZMuhammad Shahzad Zafar
Muhammad Shahzad Zafar
Malan syndrome is an ultrarare overgrowth–intellectual disability syndrome caused by NFIX variants, characterized by intellectual disability, postnatal overgrowth, and dysmorphic features. Seizures in Malan syndrome remain poorly understood. We surveyed caregivers of 53 individuals with Malan syndrome. Overall, 55% had seizures or electroencephalographic (EEG) abnormalities. Seizures occurred in 47%, with 28% experiencing drug-resistant epilepsy. The median age of seizure onset was 3 years. Epilepsy classifications included focal (40%) and unknown-onset tonic-clonic seizures (48%). Generalized tonic-clonic (8%), myoclonic (8%), and epileptic spasms (4%) were also reported. Of those with seizures, 44% had status epilepticus. Valproic acid was the most used antiseizure medication, with variable efficacy. This study represents the largest cohort to date, providing detailed descriptions of seizures in Malan syndrome, and lays a foundation for future research phenotyping epilepsy in affected individuals. Clinicians should maintain a high suspicion of seizures and monitor closely for status epilepticus in individuals with Malan syndrome.

16 June 2026 in Current Treatment Options in Neurology
Verified
Journal Article
Closed access
PDF file
SHSenyene E. Hunter
Senyene E. Hunter
ECEmma B. Cardwell
Emma B. Cardwell
JLJenna K. Lea
Jenna K. Lea
CRChethan K. Rao
Chethan K. Rao
DSDebopam Samanta
Debopam Samanta
SBSonal Bhatia
Sonal Bhatia

5 September 2025 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
APAnabel G. Puri
Anabel G. Puri
SWSean Woods
Sean Woods
JSJohn M. Schreiber
John M. Schreiber
CKCynthia G. Keator
Cynthia G. Keator
JCJason Coryell
Jason Coryell
CKCemal Karakas
Cemal Karakas